Plasmodium falciparum malaria and invasive bacterial co-infection in young African children: the dysfunctional spleen hypothesis by Gloria P Gómez-Pérez et al.
Gómez-Pérez et al. Malaria Journal 2014, 13:335
http://www.malariajournal.com/content/13/1/335REVIEW Open AccessPlasmodium falciparum malaria and invasive
bacterial co-infection in young African children:
the dysfunctional spleen hypothesis
Gloria P Gómez-Pérez1,2*, Robin van Bruggen3, Martin P Grobusch2 and Carlota Dobaño1Abstract
Children with recent or acute malaria episodes are at increased risk of invasive bacterial infections (IBI). However, the
exact nature of the malaria-IBI association is still unclear. Young children have an age-related spleen immunologic
immaturity, mainly due to the still ongoing development of the marginal zone (MZ) B cell subset. By mounting a
rapid antibody response against encapsulated bacteria, these cells are critical for the defence against highly pathogenic
microorganisms that do not elicit classical T cell-dependent responses. There is increasing evidence that the anatomy
of the spleen becomes disorganized during malaria infection, with complete dissolution of the MZ and apoptosis of
MZ B cells. Correspondingly, a reduction in the frequency of the peripheral equivalent of the MZ B cells has been found
in malaria endemic areas. A remarkable similarity exists in IBI susceptibility between African children with malaria and
hyposplenic or splenectomized patients. However, studies specifically assessing the immune function of the spleen in
controlling bacterial infections in young children with malaria are scarce.
Here, it is hypothesized that Plasmodium falciparum malaria infection constitutes a detrimental factor in the still
immature spleen function of young children, resulting in a factually hyposplenic state during malaria episodes, putting
children with malaria at a high risk to develop life-threatening bacterial infections. Studies to confirm or reject this
hypothesis are greatly needed, as well as the development of affordable and feasible tools to assess the immune
spleen function against encapsulated bacteria in children with malaria.
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For years, in malaria-endemic settings the percentage of
children with splenomegaly has been correlated with
intensity of malaria transmission in a community. The
method to evaluate malaria endemicity by spleen measure-
ment is named the Hackett score, and it was introduced by
Dempster in India in 1848 before it was known that
Plasmodium species were the causative agent of malaria.
Later, this method became accepted by the World Health
Organization to be used in malaria surveys [1,2].
The spleen is a complex lymphoid organ with several
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article, unless otherwise stated.life and reaches full maturation during early childhood,
around age two to three years [3-5]. The characteristic
that makes this organ unique is that it is the only lymph-
oid organ specialized in the filtration of blood, while the
rest of lymphoid organs filter lymph. Additionally, the
spleen contains the largest single aggregate of lymphoid
tissue in the body, housing approximately one third of
the total circulating lymphocytes, thus with a vast number
of them migrating through the spleen at any given time,
surpassing the combined traffic of all lymph nodes in the
body [6]. It is also in the spleen where a large population
of naïve B cells produced in the bone marrow matures
into memory B cells. Overall, a special attribute of the
spleen immune function is its capacity to mount T
cell-independent (TI) immune responses against poly-
saccharide and lipopolysaccharide micro-organism anti-
gens in non-immune individuals (TI-1 and TI-2 responses,
respectively). This response can take place within 24 toentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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by phagocytosis and readily production of IgM [6-8].
Hence, the spleen function ‘fills in’ the time gap between
the innate and the adaptive immune response, with the
latter taking several days to develop. The filtration of
bacteria and their destruction in the spleen must be a
rapid process in order to overcome the speed of replication
of these micro-organisms [6], a process for which the
spleen is fully equipped and in which absence, life-
threatening invasive bacterial infections (IBI) can enfold.
Therefore, the spleen represents the second line of protec-
tion against microbes when they manage to breach the
first line of protection, the mucosal barrier [9]. The unique
structure of the microvascular pathways of the spleen
(Figure 1) reflects its two most important functions: (1)
the removal of senescent and damaged red blood cells
(RBCs); and, (2) the removal of blood-borne micro-
organisms and cellular debris [10-12]. Both functions
involve an intense phagocytic activity that occurs inFigure 1 Structure of the human spleen. Adapted from Bowdler [6]. Art
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To accomplish its functions, the spleen encompasses
the following anatomic subunits (Figure 1): (1) the white
pulp (WP), containing T cell zones (periarteriolar
lymphoid sheath (PALS)) and B cell follicles, where the
adaptive immune response takes place; (2) the marginal
zone (MZ) containing macrophages, dendritic cells (DCs),
natural killer T (NKT) cells (in mice), B cell-helper neu-
trophils (NBH), innate lymphoid cells type 3 (ILC3), CD4
+
T lymphocytes, MZ B cells and memory B cells, where
TI-1 and TI-2 responses take place; (3) the perifollicular
zone (PFz), separating the MZ from the red pulp (RP) and
containing RBCs, pericapillary macrophages, NBH, and
ILC3; (4) the RP-containing macrophages, DCs, NBH,
plasmablasts, being the place where RBCs are efficiently
filtered from the circulation and where reticulocytes
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the MZ through capillaries branched from splenic cen-
tral arterioles (Figure 1). The small capillaries in the MZ
called penicilli distribute part of the blood flow to the
follicles, the PFz and the RP [6]. Penicilli have different
possible ends (Figure 1): (A) and (B) the MZ at different
points; (C) penicilli can enter the MZ and curved to end
into the B cell follicle; (D) they could reach the RP and
curve back to the external border of the MZ; (E) or they
could drain directly into the PFz and the RP. Blood
components, possibly containing foreign antigens, are
sorted in the MZ by cell-cell interactions with the immune
and endothelial cells located in this zone, to the WP or to
the RP. Distribution of the blood cells is not random.
Ninety per cent of the blood flow coming out from the
MZ is drained directly into open ended venous sinuses
(VS) or penicillin-VS connections, and from there to the
splenic venous circulation constituting the fast pathway.
Ten percent of the blood is drained into an open circula-
tion system in the PFz and the RP (slow pathway) [6,18].
The RP is constituted by a reticular meshwork with pulp
cords that form a three-dimensional web where specialized
macrophages reside. Here, in the slow pathway, immature
RBCs (reticulocytes) and abnormal RBCs adhere to the
meshwork mediated by adhesion molecules, or are be-
ing captured by macrophages due to specific signals of
immaturity, aging or damage, and no longer circulate.
Blood-borne pathogens and debris can also be captured in
the RP. Normal RBCs pass through the RP towards the
inter-endothelial slits (IES) on the walls of the blind-
ended VS located in this area, trespassing into the VS
lumen and going back into the peripheral circulation
(Figure 1). All this ‘stickiness’ slows down the speed of
RBC flow into the VS, because even normal RBCs tran-
siently adhere to the reticular meshwork, reaching
the RP haematocrit concentrations as high as two-fold the
arterial haematocrit (~80%), representing 75% of the
spleen volume in normal conditions [6]. Damaged sen-
escent RBC can also be captured in the RP by mechan-
ical retention. Nevertheless, the 90 to 10% differential
distribution of the blood flow in the spleen to the
lymphocyte-RBC compartments, respectively, suggest
that the immunological function of the spleen takes
priority over the filtration of blood cellular elements in
the RP [6]. Importantly, all this extremely organized
biophysical distribution of the blood and its cellular
components into the different subunits of the spleen is
disrupted in malaria infection [17,19,20].
Plasmodium falciparum malaria causes alterations in
the function of the cells of the innate immune system
such as macrophages [21], neutrophils [22] and dendritic
cells [23]. It also produces changes in the adaptive im-
mune system, altering B cell populations [24-26] and the
response to certain vaccines [27]. Regulatory cytokinesreleased during acute infection aiming to control the
pro-inflammatory response against malaria parasites [28]
could impair the mucosal immune response to invasive
non-typhoid salmonellae (NTS) infections [29]. Currently,
there is increasing evidence in the scientific literature that
young children (<three years old) infected with malaria
might suffer from functional hyposplenism. Here, it is
hypothesized that P. falciparum infection impairs the im-
munological response of the spleen against encapsulated
bacteria in young children, a postulate built upon the
following observations.
Observation 1. Children with malaria are similar to
splenectomized patients or patients with hyposplenism
regarding their susceptibility to IBI
One of the risk factors to develop IBI in Africa is P. fal-
ciparum malaria [30-33]. Bacteria responsible for these
invasive infections in patients with malaria are NTS,
Streptococcus pneumoniae, Haemophilus influenzae type
b, Staphylococcus aureus, Escherichia coli and other gram-
negative bacteria [30-32,34-37]. Reported specific risk fac-
tors to develop NTS bacteraemia are: younger age, acute
and recent malaria infection, severe malarial anaemia
(SMA), splenomegaly, human immunodeficiency virus
(HIV) and severe malnutrition [32,33,36,38-44]. There-
fore, it is well established that African infants younger
than 36 months bear the brunt of malaria infection,
presenting with the highest rates of IBI co-infection
compared with older children and HIV-negative adults
[33,42,43]. Remarkably, splenectomized patients or those
with hyposplenic states are well known to be susceptible
to develop serious IBI by this same group of bacteria
[45-55]. For example, it is common knowledge that
splenectomized patients are susceptible to overwhelm-
ing post-splenectomy infection syndrome (OPSI), which
consists of a fulminant sepsis mainly caused by S. pneu-
moniae, characterized by a particularly high mortality
[45]. Of note, among splenectomized patients, infants
and young children are at higher risk for IBI than adults
[54]. The reason is that young asplenic children have
low pre-existing circulating antibodies and, in the absence
of the spleen, are unable to mount a sufficiently fast
antibody response against intravascular antigens and
to phagocytose antibody un-opsonized bacteria while
the adaptive immune response is under development
[6]. Conversely, the splenectomized adult population
tends to have pre-existing antibodies due to a larger
immunological memory repertoire compared to very young
children, overcoming the necessity for developing a fast
immune response and controlling the infection. These
immune complexes in the absence of the spleen can
then be phagocytosed in the liver by Kupffer cells [6,56],
although less efficiently than in the spleen, explaining the
occurrence of IBI also in adult splenectomized patients. A
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ease (SCD) individuals [11,45,49,55,57-59]. Interestingly,
as in the case of splenectomized children, infants and
young children with SCD are at higher risk of IBI when
compared to the adult population [57]. Children with
SCD (homozygous genotype) under five years of age
present IBI by S. pneumoniae at rates 30–100 times higher
than those expected in healthy children from the same age
group [58]. Splenic dysfunction is the foremost contribu-
tor to the enlarged risk.
What are the underlying immunological mechanisms that
make hyposplenic subjects, especially young children,
susceptible to IBI?
Opsonization is impaired in the absence of spleen
Routinely, hyposplenism has been diagnosed by haemato-
logical rather than immunological methods [6]. Neverthe-
less, Lammers et al. [11] have performed a study in SCD
patients (homozygous (SS) and heterozygous (SC) geno-
type) and splenectomized patients, aiming at correlating
the results of spleen haematological function tests with
conventional methods, to the immunological spleen func-
tion and peripheral B cell subsets in these different hypos-
plenic individuals as compared to control subjects. The
methods used to assess the haematological function of the
spleen were (i) Howell Jolly bodies (HJB) assessment; (ii)
pitted red cell count; and, (iii) 99mTc-labelled autologous
RBC scintigraphy to measure functional splenic volumes
(FSV). The immunological function was assessed by
studying the response to polysaccharide vaccines. As
expected, SS and SC individuals had a significantly dimin-
ished anti-polysaccharide response. Interestingly, HJB were
indicative of splenic dysfunction; however, its absence did
not necessarily indicate a normal functioning spleen tissue.
Even more interesting, the FSV was strongly correlated
with the amount of MZ B cells in peripheral circulation,
being significantly reduced in SS and splenectomized pa-
tients, thus corroborating previous findings [60]. These
results indicate that the MZ B cell subset population
might be reduced in the spleen of hyposplenic individuals,
with the consequently impaired immune response to
encapsulated bacteria and reduced IgM response. These
results are in correlation with the well-established
functional opsonization failure in hyposplenic patients
[58,61,62]. An illustration of this defective opsonization is
found in a clinical case report of a patient with SCD who
presented with refractory septic shock. Despite aggressive
therapy, the patient remained on two vasopressors and
yielded persistent bacteraemia. Within one day of starting
intravenous g-globulin, vasopressors could be discontin-
ued, indicating a quick response to the g-globulin infusion
as a rescue therapy [63].
Additionally, in the spleen tuftsin is synthetized, an op-
sonin that activates the alternative complement pathway[6,17], and that has receptors expressed on monocytes/
macrophages, neutrophils and NK cells [64]. Upon bind-
ing its receptor, the complex is taken into the phagocyte
and initiates the production of superoxide and nitroxide
radicals, essential molecules for the killing of phagocy-
tosed bacteria [64]. Therefore, the main outcome of tuftsin
binding to macrophages and neutrophils is the stimulation
of the ability of these cells to digest that leads to termin-
ation of phagocytosis in lymphoid formations [64]. Its
importance has been confirmed by the development of
fatal infections in splenectomized humans and other ani-
mals with lack of tuftsin [64]. Moreover, serum tuftsin
concentrations are decreased in SCD subjects, causing a
functional defect in the alternative complement pathway
[65,66]. Importantly, tuftsin derivatives and analogues
such as polytuftsin and rigin have been tested as thera-
peutic tools in several macrophage-based infections [67],
showing to increase anti-tuberculosis drug treatment
uptake by macrophages [68]. Tuftsin has also been used
as a malaria and influenza A vaccine adjuvant [69-71],
as a prophylactic in malaria animal models improving
infection control [72], and as an immune-stimulating
molecule along with antifungal agents in the treatment of
opportunistic fungal infections [73]. In addition, combined
anti-leishmanial drug treatment with tuftsin increases
Leishmania parasite phagocytosis by macrophages [74],
and when used as adjuvant treatment it helps to control
sepsis in a murine model [75].
Neutrophil and monocyte dysfunction
Patients with malaria infection and SCD present with
neutrophil dysfunction, characterized by defective loco-
motion, phagocytic processes and bactericidal perform-
ance [22,66,76], related to a poor or almost absent
oxidative activity in a subpopulation of neutrophils [66].
Additional studies show similar alterations in the mono-
cyte subsets as well, related to haemolysis itself, but
overall due to a direct toxic effect of iron liberated from
malarial pigment (haemozoin) and through adhesion of
infected RBC (iRBC) to monocytes, macrophages and
myeloid DC surfaces [21,23,76,77]. Therefore, patients
with SCD and malaria, as well as patients with other
haemolytic diseases such as bartonellosis, are unusually
susceptible to bloodstream invasion with Salmonella
spp. [78]. In children with mostly (95%) uncomplicated
P. falciparum malaria, with ages between four and eight
years, it was found that the neutrophil dysfunction was a
consequence of induction of a haem-degrading enzyme
(haem oxygenase-1) in neutrophil progenitors in the bone
marrow [22]. The dysfunction in oxidative burst activity
did not affect the whole neutrophil population and it was
long-lasting, recovering normal function only eight weeks
on average after a malaria episode. However, in this study
it was not possible to establish the threshold of proportion
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order to increase the susceptibility of malaria patients to
NTS bacteraemia. Neither was it possible to explain why
young children are more susceptible to NTS systemic in-
fections than immune-competent adults, since neutrophil
dysfunction due to falciparum malaria could also occur in
the adult population during malaria episodes. As the
phagocytosis by mononuclear cells and neutrophils is en-
hanced in the presence of antibodies, and in SCD patients
bacterial phagocytosis is substantially improved with im-
munoglobulin (Ig) treatment [63], here it is proposed that
neutrophil dysfunction may be contributing to the in-
creased susceptibility to IBI in young children with
malaria [22], but it is not the most important factor.
Observation 2. MZ B cells are decreased in children with
malaria
As aforementioned, one of the anatomic subunits of the
spleen tissue is the MZ. The MZ of the spleen is stra-
tegically positioned between the lymphoid compartment
of the spleen, the WP, and the more innate, scavenging
RP compartment (Figure 1). Most of the arterial blood
that enters the spleen runs through the MZ inhabited by
a special set of cells, such as macrophages expressing
unique combinations of pattern recognition receptors, as
well as MZ B cells that can be readily activated [19]. MZ
B cells are a distinct B cell lineage [79] with a unique
surface phenotype, expressing polyreactive IgM (B cell
receptor: BCR), IgD, CD1c, CD35 (complement receptor
1 (CR1)), CD21 (complement receptor 2 (CR2)), CD27,
high levels of Toll-like receptors (TLR), MHC class II,
and TACI (an Ig-inducing receptor) [13,80]. Through
the dual binding of antigens to the BCR and TLR, MZ B
cells are promptly activated, undergoing Ig class switching
and somatic hyper-mutation in a T cell-independent man-
ner. In mice it has been shown that under certain stimuli,
and using CR1, CR2 and the chemotactic receptors S1P1
and CXCR5, MZ B cells migrate, shuttling antigens to the
B cell follicles [81], returning afterwards back to the MZ.
When only the BCR is stimulated, MZ B cells migrate to
the T cell zone to develop a T cell-dependent antibody
response. Through TACI receptors, MZ B cells receive
assistance by the NBH to produce IgM and for class
switching from IgM to IgG or IgA in a T cell-independent
manner [16]. Other important populations in the MZ are
the already mentioned macrophages as well as DCs, ILC3
and switched memory B cells [9]. NKT cells have
been found in human spleen tissue [82]; however, its
localization within the spleen is not clear. In mice on
the other hand, NKT cells have been found in the MZ and
RP initiating protective immune responses against blood-
borne antigens [14].
Depletion of cells in the MZ during acute malaria in-
fection was reported in the Plasmodium chabaudi ASinfection mouse model [83]. Later on, Urban and col-
laborators found a marked dissolution of MZ with loss
of B cells in human spleens of adult patients dying
from P. falciparum malaria although not significant
[84]. Recently, it was shown that acute P. chabaudi AS
infection in mice causes apoptosis of transitional T2
and MZ B cells during and subsequent to the control
of the first wave of parasitaemia [85]. These findings
have been corroborated by several reports of apoptosis
of different immune cells in the spleen in malaria animal
models [86-89]. A proposed underlying mechanism of
reduced B cells in the spleen is the impaired generation
of bone marrow MZ B cell precursors. Regarding the
malaria-driven apoptosis mechanism, it has been pro-
posed to be mediated by pro-inflammatory cytokines
such as TNF [13], functional exhaustion of the MZ due
to abnormally high influx of parasitic antigens [12,13],
and the synergy between the accumulation of free
haem in plasma during Plasmodium infection and TNF
production, that mediates programmed cell death in
immune cells [90].
As explained, the development of peripheral B cells
takes place during infancy. However, in malaria-endemic
settings some alterations in B cell subsets independent
of age have been reported [91]. For instance, a study per-
formed in western Kenya found suppression of circulating
IgD+CD27+IgM+ B cells (the peripheral equivalent of MZ
B cells) in infants aged one to 24 months living in a
malaria-endemic region when compared with a similar
infant population from an unstable malaria transmission
region [91]. Supporting these findings, it has been re-
ported that four- to five-year old children in Uganda
with the highest incidence of malaria in the prior year of
the study (> = seven episodes/year, n = 20) exhibited a
transient drop in frequencies of IgD+CD27+IgM+B cells
at the time of acute malaria, not seen in subjects with a
lower incidence [92]. A recent study performed at the
Barcelona Centre for International Health Research
(CRESIB) also shows a decrease of MZ-like peripheral
B cells in pregnant women from Papua New Guinea with
life-long exposure to Plasmodium infections (Requena
et al., in press J Immunol). Here, it is hypothesized that
the drop of the MZ B cells in peripheral circulation of
patients with malaria is a result of the disruption in spleen
architecture observed in the referred histology studies.
Furthermore, the MZ B cell deficiency along with some
other possible defective immune spleen functions appears
to be responsible for a transient hyposplenism in children
with malaria, increasing their risk to IBI. Importantly,
children with malaria have been reported to show a
lower antibody response against group C meningococ-
cal polysaccharide vaccines when compared to children
from the same setting but without parasitaemia, sup-
porting this hypothesis [27]. In line with this finding,
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including diphtheria toxoids, is lost in animal models after
malaria episodes by deletion of memory B cells and long-
lived plasma cells in spleen and bone marrow [93].
Taking into account that the spleen MZ has not yet
reached maturity in young children, it can be speculated
that the threshold of MZ dysfunction (due to falciparum
malaria or other pathologies) that is needed to develop
immune hyposplenism is lower in children when compared
to the adult population, probably explaining children’s in-
creased susceptibility to bacteraemia in the context of mal-
aria infection when compared to the immune-competent
adult population.
It is important to clarify that the peripheral equivalent
of the MZ B cells have different nomenclatures in the
research literature: MZ-like B cells, IgM memory B cells
[94], splenic MZ B cells (S-MZ B cells) [7], IgD + IgM +
CD27+ B cells, IgD + CD27+ B cells [91] and CD27 +
IgM + B cells.
Observation 3. Antibody and complement are necessary
to control NTS invasive infection
NTS bacteraemia most commonly occurs in African
children below two years of age. A relative sparing of
infants younger than four months old has been found
coincidently within the period during which maternal
antibodies are still present [95]. Sera from healthy children
less than 16 months old were shown to lack NTS-specific
antibodies, and sera lacking antibodies did not kill NTS
despite normal complement function [96]. Additionally,
Salmonella-specific antibodies facilitate specific T cell
responses via augmentation of bacterial uptake and
induction of apoptosis in macrophages [97]. Moreover,
transferred low- and high-affinity IgG2c, and with less
efficiency IgM, were shown to impede Salmonella
colonization of splenic macrophages, markedly reducing
bacteraemia by antibodies induced during the infection in
mice [98]. Therefore, as the fast antibody response against
encapsulated bacteria is developed in the spleen, here it is
postulated that malaria-induced hyposplenism could be
responsible for a defective immune response against NTS
and other encapsulated bacteria in children with malaria,
substantially increasing their risk to develop IBI.
Observation 4. Children with SMA have a higher prevalence
of IBI co-infections than children with cerebral malaria
A study in Sudanese children reported that SMA was
associated with a larger spleen, longer fever duration
and lower parasitaemia than cerebral malaria (CM) [99].
In these children, SMA and CM clinical presentation
differed significantly in several aspects, including median
age (three versus six years), prevalence of splenomegaly
(57 versus 11%), and spleen size (Hackett grade 3.5
versus 0). Recently, a study reported that spleen volumemeasured by ultrasonography was lower in children with
CM compared with children with SMA [100]. Interest-
ingly, similar results were found some decades ago in an
animal model of malaria infection in which resistant
mouse strains developed marked splenomegaly and sur-
vived the infection, whilst susceptible mice succumbing
to the infection developed only minimal splenomegaly
[83]. In humans, SMA is more prevalent in children youn-
ger than two years old in holo-endemic areas [18,99,101].
Therefore, there is an age-dependent variation of iRBC
clearance, with older patients having less efficient parasite
clearance than young children, suggesting an innate reten-
tion process [99]. Previous findings reported that patients
with malaria and splenomegaly markedly accelerated
clearance of 51Cr-labelled RBC and presented with a lower
mean haematocrit than patients without splenomegaly
[102]. Filtration-based parasite clearance is likely the key
to spleen-dependent innate protection [99]. However, how
this innate function of the spleen protects against malaria
parasites and how the retention of iRBC and uninfected
RBC (uRBC) in this organ influences immunologic re-
sponse in the young host has not yet been studied.
Of note, several studies have shown that children with
SMA have a higher prevalence of IBI co-infections (largely
NTS bacteraemia) compared with children with CM who
infrequently have bacterial co-infections [32,33,103].
The increased malaria parasite clearance in SMA would
explain the reported tendency of children with malaria
and IBI co-infection to have lower parasite densities
[31,33,103], as well as the low frequency of NTS infection
in children with high malaria parasite counts [43,104].
Therefore, the ‘SMA-IBI-young age’ association needs to
be elucidated. A possible innate mechanism that could
explain the prevalence of SMA in young children is the
age-related change in RBC complement regulatory
proteins (CRP) [101,105,106]. The detailed discussion
of this possible mechanism is beyond the scope of this
manuscript. Briefly, CRPs are in low concentration on
the surface of RBC in young children, increasing the
splenic erythrophagocytosis of iRBC and uRBC during
malaria infection, as compared to the adult population
[107,108], with the consequent development of spleno-
megaly. It has been found that splenomegaly in malaria
patients is the result of splenic accumulation of iRBCs,
uRBCs, macrophages, and reticular cells [99], among
other cells. It was mentioned earlier that under normal
conditions the splenic RP reaches a haematocrit of 80%.
Therefore, during malaria infection, the increased amount
of entrapped RBCs in the RP requires some tissue rear-
rangements. Two animal models illustrate two different
possible situations in the presence of Salmonella typhimur-
ium or S. pneumoniae bacteria with parasitic co-infection
of the spleen. Apparently, co-infection by a non-lethal Plas-
modium strain and S. typhimurium in mice does not alter
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teria in the spleen [109]. Malaria iRBC in these experiments
were located in the RP, and bacteria were located in the
MZ (Figure 2A). Taking all limitations of the mouse
model into account, both micro-organisms were success-
fully cleared, demonstrating conserved haematological
and immunological spleen functions despite the concomi-
tant infections. Another research group decided to test
the bactericidal function of the spleen in the absence of
MZ. Mice with chronic Leishmania donovani infection
(which presents with progressive loss of macrophages
in the MZ in direct relation to splenomegaly) were co-
infected with S. pneumoniae. In this case, in the absence
of MZ macrophages, bacteria were located in the RP in-
stead of the MZ, and phagocytosed by RP macrophages,
showing a relocalization of the bactericidal functions in
the spleen [110] (Figure 2B). However, here it is postulated
that in the case of invasive bacterial co-infection with a
lethal malaria parasite strain, such as P. falciparum, this
relocalization will not occur due to overload of RBC in the
RP, among other factors. In human P. falciparum malaria,
similarly to the L. donovani-S. pneumoniae co-infection,
the MZ would be significantly reduced. Nevertheless,
some important differences with this animal model would
be: 1) the chronicity of infection in this L. donovani ani-
mal model, in contrast with acute P. falciparum malaria in
humans, perhaps implying that the total phagocytic cap-
acity of the spleen RP is not necessarily overwhelmed in
chronic Leishmania infections - even though in massive
splenomegaly cases of L. donovani in humans, the im-
portant structural changes in the spleen might impact
its immunological function; 2) the high parasitaemia
and splenic overload with iRBC and uRBC in the case ofFigure 2 Parasite and bacteria co-infection in the rodent spleen. A. Pl
rodent spleen. Adapted from Yavada et al. [109]. The white pulp (periarterio
zone (MZ) do not show atrophy and preserve their function. B. Leishmania
spleen. Adapted from Kirby et al. [110]. The white pulp and the MZ are notorio
amastigotes of L. donovani. In the absence of MZ, S. pneumoniae localized in the
CA: central arteriole; VS: venous sinuses; RBC: red blood cell; iRBC: infected RBC;
zone B cells. The perifollicular zone (PFz) was not drawn in these Figures.P. falciparum malaria, added to the increased erythro-
phagocytic capacity in young children, that will demand
maximum phagocytic capacity from the macrophages in
the RP and the MZ [111] (Figure 3). Importantly, in the
case of falciparum malaria, even if bacteria reach the RP,
the chances to be phagocytosed there will be low. The
reason is the evidence arising from experiments per-
formed in in vivo animal models and in vitro [78]. These
studies show that macrophages simultaneously exposed
to damaged RBC and S. typhimurium organisms preferen-
tially phagocytose damaged RBC, presenting a defective
bactericidal capacity. The reasons are not clear. It is
postulated that inhibition of bacterial phagocytosis may
be mediated by competition mechanisms between damaged
RBC and bacteria for phagocytic sites on macrophages, or
that macrophages are just overloaded temporarily [111].
Putting two and two together
Synthesizing the above information, it is evident that due
to innate mechanisms, African children younger than
three years old develop SMA with accompanied spleno-
megaly more frequently than older children and adults.
The changes in the immune cell architecture of the spleen
under these circumstances might affect the immuno-
logical function of this organ against encapsulated bac-
teria. Initially by disruption and almost disappearance
of the MZ and its important fast bactericidal function,
but also by impairing other spleen functions like the
production of tuftsin, presenting opsonization failure
and defective function of the alternative complement
pathway. In P. falciparum infections, the phagocytic
capacity of the spleen in young children might be satu-
rated, with RP macrophages preferentially phagocytosingasmodium chabaudi – Salmonella typhimurium co-infection in the
lar lymphoid sheaths (PALS) and B cell follicle) and the marginal
donovani – Streptococcus pneumoniae co-infection in the rodent
usly atrophic, showing great amounts of macrophages with phagocytosed
red pulp (RP) where RP macrophages compensate the MZ dysfunction.
MØ: macrophages; PC: plasma cells; DC: dendritic cells; MZ B cells: marginal
Figure 3 Plasmodium falciparum and invasive bacterial co-infection in the human spleen. The marginal zone (MZ) during P. falciparum
malaria is dissolved, therefore lacking its most important armamentarium against encapsulated bacteria. The red pulp (RP) macrophages
phagocytic capacity is overload by erythrophagocytosis, and in the presence of infected erythrocytes, macrophages will deficiently phagocytose
bacteria. Bacteria replicate rapidly causing bacteraemia. (MØ) macrophages; (VS) venous sinuses. Penicilli and perifollicular zone (PFz) were not
incorporated into this Figure.
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http://www.malariajournal.com/content/13/1/335iRBC over bacteria [78,111]. As a consequence, in the case
of a bloodstream invasion of bacteria at the same time as
P. falciparum infection, bacteria will find the MZ almost
inhabited and the RP macrophages busy and skewed to
iRBC and uRBC phagocytosis. Subsequently, bacteraemia
takes place (Figure 3 and 4).
Additional mechanisms
Bacterial carriage status
It is highly likely that children who develop malaria-IBI
co-infection are carriers of the causative bacteria when
they develop malaria infection. There is evidence that
6.9% of household contacts of children with IBI by NTS
are asymptomatic carriers of NTS in the stools, including
healthy children [112]. Additionally, NTS seems to behave
like an opportunistic infection [29,113,114], being highly
prevalent among adult HIV patients, with a 23% preva-
lence of NTS found in spleen tissue from adult HIV indi-
viduals dying from a different cause [44]. This carriage
state postulate is underpinned by the clinical case of a
14 month old child that presented with an invasive in-
fection by S. typhimurium after splenectomy due to
acute spleen torsion [115]. This is a very close analogy
to cases of young children with malaria - an otherwise
healthy child, possibly carrier of NTS in the intestine,who suddenly suffers from a hyposplenic state due to a
surgical resection of the spleen, which in the case of young
African children would be represented by hyposplenism
caused by P. falciparum malaria infection.
Malaria infection impairs mucosal inflammatory response
As mentioned, NTS cause high rates of life-threatening
bacteraemia in the immune-compromised host and in
infants in sub-Saharan Africa, resulting in mortality rates
surpassing 20% despite antibiotic treatment [29,113].
Mucosal barriers represent the first line of defence against
bacteria, where lymphoid tissues located between the host
and the environment endow with immune cells capable to
mount innate and adaptive immune responses against
these pathogens [9]. Once bacteria have penetrated the
mucosal barrier, the invading micro-organism translocates
to the intestinal lymph follicles and the draining mesen-
teric lymph nodes (MLNs), and some pass on to the
reticulo-endothelial cells of the liver and spleen [113]. It
has been postulated that malaria infection favours bacteria
translocation from the intestinal lumen to the blood, with
animal models clearly proving this hypothesis by isolating
S. typhimurium from liver and spleen by approximately
1,000-fold in animals co-infected with malaria when com-
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studies in non-human primate and murine animal models.
In these experiments, malaria infection led to increased
recovery of S. typhimurium from the draining MLNs in
mice. Furthermore, malaria infection caused a global
suppression of gut inflammatory response and reduced
significantly the neutrophil influx to intestinal mucosa,
characteristic of NTS infection. IL-10 produced during
malaria infection, an anti-inflammatory cytokine whose
function is to control the pathogenic inflammatory re-
sponse against malaria parasites [28], was found to
contribute to the suppression of mucosal inflammatory
response to invasive NTS in these animal models.
However, further mechanisms for bacterial transloca-
tion from mucosal surfaces in malaria patients need to
be explored; for instance, to study the impact of a
reduced amount of circulating MZ B cells in children
with malaria in mucosa immune response, since in
humans MZ B cells are also located in the subepithelial
area of mucosa-associated lymphoid tissues (MALT),
including Peyer’s patches and the epithelium of tonsilar
crypts [13].
Vitamin A deficiency
Immune cells have homing molecules resembling ‘im-
mune post-codes’ allowing them to be recruited to specific
organs, such as the intestine or skin [116]. Hence, vitamin
A plays an important role in the intestinal immune systemas a source of retinoic acid (RA), a gut-homing factor for
IgA secreting cells in intestinal mucosa [117,118]. Further-
more, intestinal epithelial cells send signals through RA to
DCs in the gut lamina propria promoting IgA class
switching in local B cells [118]. It has been shown some
decades ago that malnourished vitamin A-deficient rats
exhibit impaired migration of recently activated mesen-
teric lymphocytes, in addition to a marked decrease in the
number of IgA-antibody secreting cells and CD4+ T cells
in the ileum [117]. Moreover, gestational vitamin A defi-
ciency in animal models has been shown to reduce the
intestinal immune response by decreasing the number of
immune cells in rat offspring [119] and controlling the
size of secondary lymph organ and the efficiency of
immune responses in the adult mouse offspring [120]. As
severe malnutrition is one of the risk factors to develop
malaria-IBI co-infection, it is important to evaluate the
impact of vitamin A administration in the clinical man-
agement of children with malaria and IBI-co-infection in
Africa, either as a therapeutic and/or prophylactic meas-
ure, especially due to recent evidence of the positive
impact of vitamin A and zinc supplementation on malaria
morbidity in a study conducted in Ghana [121,122]. How-
ever, in man, the role of vitamin A in malaria pathogenesis
is multifaceted, and P. falciparum clearly benefits from
normal to high vitamin A hepatic stores, possibly depend-
ing on scavenged vitamin A metabolites to destabilize host
RBC membranes facilitating invasion [123].
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If splenomegaly and the excessive B cell stimulation in
the spleen are the cause of immunological hyposplenism
in young children with malaria, it should be expected
that patients with other parasitic diseases that cause
splenomegaly also develop an increased susceptibility to
IBI. There are few reported cases in the literature of
increase susceptibility to IBI by NTS in cases of leishman-
iasis [124,125] and schistosomiasis [126,127]. Although, in
the latter co-infection, some more complex mechanisms
related to adhesion of bacteria to the Schistosoma par-
asites might be related to recurrent NTS infection. It is
interesting that in the case of schistosomiasis, the in-
creased risk to IBI by NTS is also apparently restricted
to young children [128]. However, the case of Plasmo-
dium vivax malaria and the weak correlation of this
infection with IBI is a matter of reflection, especially
taking into account that P. vivax malaria presents more
frequently with massive splenomegaly than P. falciparum
malaria. That notwithstanding, the concomitant infection
of Salmonella typhi and P. vivax is well established
[129-134]. However, the postulated mechanism of this
association is the activation of vivax malaria hypnozoites
by systemic parasitic and bacterial infections, with little
current evidence of P. vivax malaria association with other
bacterial infections [135]. What could be the explanation
for such a prominent splenomegaly without evident im-
mune hyposplenism? A possible mechanism is that in the
case of P. vivax malaria, the inflammatory response of the
B cell subset in the spleen is different, meaning that des-
pite the important capture of infected reticulocytes in the
spleen of P. vivax malaria patients, the immune reaction is
somehow not as strong as in the case of P. falciparum
malaria (that infects both reticulocytes and mature RBC),
therefore not causing a major impact on MZ function. A
possible hypothesis to explain this phenomenon could
be that P. vivax malaria, by infecting reticulocytes, is
protected by their CD47 membrane protein, a potent
“do not eat me” signal to macrophages in the spleen
[136]. Interestingly, CD47 is expressed to a higher level
in reticulocytes than in mature RBC [137,138]. The “do
not eat me” signal provided by CD47 has been proven
to be strong enough to prevent phagocytosis of antibody
opsonized tumour cells when these cells express high
quantities of CD47 [139]. Therefore, the expression of
CD47 may just be high enough to prevent phagocytosis
after P. vivax infection. In addition, CD47 has been shown
to undergo a conformational change after oxidation, a
state that will lead to an “eat me” configuration, which will
result in phagocytosis by RP macrophages [136]. It is well
known that Plasmodium infection leads to reactive oxygen
species (ROS) formation, which may lead to oxidation of
CD47 and thus the “eat me” configuration of this protein.
Reticulocytes, however, have a far better capacity to handleoxidative damage than mature RBC. Thus, infection of re-
ticulocytes by P. vivax may not lead to CD47 oxidation
and the switch from “do not eat me” to “eat me” signal
would not take place, whereas during infection of mature
RBC CD47 may be well oxidized. Together, the higher
expression of CD47 and the better protection of reticu-
locytes against ROS generation might explain the accu-
mulation of a big amount of infected reticulocytes in the
spleen and the consequent splenomegaly in P. vivax
malaria, due to the inability of RP macrophages to
phagocytose them. In the case of this hypothetical incap-
acity of the RP to phagocytose P. vivax–infected reticulo-
cytes, it is possible that different immunological pathways
are triggered when compared to P. falciparum malaria,
perhaps affecting in a different way or to a lesser extent
the MZ immune cell compartment of the spleen.
Additionally, it is important to clarify that the human
spleen has remarkable differences compared to the murine
spleen, for instance regarding its microcirculation (open
in mice, closed and open in humans) and anatomic char-
acteristics (absence of perifollicular zone in mice; absence
of marginal sinus in humans) [10,13,94]. Also, MZ B cells
do not circulate in mice, while they do in humans. There-
fore, animal models were included here as a source of
valuable information about the dynamic changes of im-
mune cells in this organ in the context of bacterial and
parasitic infections, because such studies are not possible
to perform in humans. However, this information should
be carefully examined and not directly translated to the
human case.
Concluding remarks
There is ample evidence in the scientific literature to
support the hypothesis postulated here that African chil-
dren younger than three years of age might present with
immunological spleen dysfunction triggered by P. falcip-
arum malaria infection. However, malaria-dependent
hyposplenism could possibly affect older children in sub-
Saharan Africa as well. This hypothesis is based upon
several observations in human spleen histology studies
and immune cells in peripheral blood, indicating alter-
ations in the structure and function of the spleen, particu-
larly of the MZ. Animal models, with their acknowledged
limitations, were analysed as well in detail and corrobo-
rated these findings, opening new questions that need to
be urgently addressed in the human host. Testing the
dysfunctional spleen hypothesis postulated here would
have important implications for bedside care of African
children with malaria.
For instance, the development of simple and affordable
methods to assess the immune spleen function in children
with malaria and other parasitic diseases that colonize the
spleen should be a priority because current tools are
largely oriented to evaluate the haematological but not the
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http://www.malariajournal.com/content/13/1/335immunological function of this organ. Importantly, as
young children lack protective antibodies against several
encapsulated bacteria when they face a P. falciparum in-
fection, it is necessary to evaluate the role that adjuvant
intravenous g-globulin and/or tuftsin treatment could
play in helping them overcome their splenic opsonization
failure when encountering malaria-IBI co-infections. In
this regard, it should be a main concern to accelerate the
introduction of several vaccines missing in the expanded
programme on immunization in most African countries.
In addition, the risk of malaria-IBI co-infection in children
from these countries should be taken into account by
international organizations and funding sources sup-
porting vaccine introduction in poor countries to
orientate their immunization strategies, as well as to
increase their investment in research and development
of vaccines against NTS.
Assuming that bacteria colonize mucosal surfaces in
children and, in the presence of malaria infection, trans-
locate to the bloodstream, it would be important to
evaluate the role of probiotics in improving the immune
response to IBI in very young children at the first line of
defence against these pathogens: the mucosal barrier.
Some studies have shown that oral probiotic treatment
importantly reduced late onset sepsis in newborns [113],
remarkably even against S. pneumoniae infection [140].
Of note, the microbiota plays a key role in regulating the
host immune system [113,141], and in the specific case
of the genus Salmonella, optimizes its response against
this micro-organism and mediates pathogen clearance
[113]. On the other hand, in some cases prophylactic
antibiotic therapy is indicated in children in resource-
limited African countries to prevent bacterial infections
due to the limited access to health facilities and the diffi-
cult medical follow-up. However, as antibiotic treatment,
reduces the gut microbiota, it is important to be cautious
when given this prophylaxis in children with severe
malaria, since the impact on the immune system of the
gut could be deleterious, besides the risk of developing
antibiotic resistance. Therefore, it is necessary to evaluate
the role of probiotics as prophylactics against IBI, as well
as adjuvant therapy during and after treatment of bacterial
infections, to help the maturity of the immune system and
to overcome the effect of antimicrobials in the gut micro-
biota, respectively, to reduce the morbidity and mortality
of bacterial infections in young children.
The time gap between generation of knowledge and its
application where is greatly needed is unfortunately long.
The aim of this review is to reduce this time gap as
much as possible by sharing information considered of
value for the malaria research community. The proposed
dysfunctional spleen hypothesis needs to be confirmed or
rejected by studies in human subjects directly addressing
the immune spleen function, since no studies of this kindhave ever been performed in African children with mal-
aria. Meanwhile, a general awareness to the health care
providers that young children with P. falciparum malaria
should be treated as hyposplenic patients is advised.
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